Machine learning approach for culprit drug identification based on drug-specific interferon-gamma releasing cells and clinical parameters in non-immediate drug hypersensitivity

Abstract

This study aims to evaluate diagnostic utility for interferon-gamma enzyme-linked immunospot assay (ELISpot) and clinical parameters against drug provocation test (DPT) in predicting drug-induced non-immediate hypersensitivity using a machine learning approach.